Glenmark Pharmaceuticals OTC
FDA Approved Drugs

Glenmark Pharmaceuticals OTC

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

OTC
  • Total Records 10
  • Latest Approval Date Mar 16, 2026
  • Data Source FDA
  • First Approval Date Mar 07, 2005
All
84
View
Unclassified
5
View
Discontinued
22
View
OTC
10
View
RX
47
View
Company Overview

Company

Glenmark Pharmaceuticals OTC

Country

India

Website

Visit Website

Email

india_marketing@glenmarkpharma.com

Social Profiles

Company Snapshot

Glenmark Pharmaceuticals OTC

Glenmark House, B. D. Sawant Marg, Chakala, Off Western Express Highway, Andheri (E), Mumbai - 400 099

India

www.glenmarkpharma.com/ india_marketing@glenmarkpharma.com View on Map
FDA Approved Drug Records ( 10 records )
2010
01 Jul
OTC Application: 91314

Drug Name

ADAPALENE

Product Number

1

Dosage Form

-

Strength

0.1%

Approval Date

2010-07-01

91314 / 1

Active Ingredient

ADAPALENE

Application Number

91314

Product Number

1

Dosage Form

-

Strength

0.1%

Approval Date

2010-07-01

Regulatory Status

OTC

2007
28 Dec
OTC Application: 78427

Drug Name

CETIRIZINE HYDROCHLORIDE ALLERGY

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2007-12-28

78427 / 3

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

78427

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2007-12-28

Regulatory Status

OTC

2007
28 Dec
OTC Application: 78427

Drug Name

CETIRIZINE HYDROCHLORIDE ALLERGY

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2007-12-28

78427 / 4

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

78427

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2007-12-28

Regulatory Status

OTC

2024
11 Jun
OTC Application: 218092

Drug Name

ESOMEPRAZOLE MAGNESIUM

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2024-06-11

218092 / 1

Active Ingredient

ESOMEPRAZOLE MAGNESIUM

Application Number

218092

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2024-06-11

Regulatory Status

OTC

2005
07 Mar
OTC Application: 77146

Drug Name

FAMOTIDINE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2005-03-07

77146 / 1

Active Ingredient

FAMOTIDINE

Application Number

77146

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2005-03-07

Regulatory Status

OTC

2010
04 Aug
OTC Application: 90837

Drug Name

FAMOTIDINE

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2010-08-04

90837 / 1

Active Ingredient

FAMOTIDINE

Application Number

90837

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2010-08-04

Regulatory Status

OTC

2026
16 Mar
OTC Application: 218742

Drug Name

FLUTICASONE PROPIONATE

Product Number

1

Dosage Form

-

Strength

0.05MG/SPRAY

Approval Date

2026-03-16

218742 / 1

Active Ingredient

FLUTICASONE PROPIONATE

Application Number

218742

Product Number

1

Dosage Form

-

Strength

0.05MG/SPRAY

Approval Date

2026-03-16

Regulatory Status

OTC

2012
18 May
OTC Application: 202727

Drug Name

LANSOPRAZOLE

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2012-05-18

202727 / 1

Active Ingredient

LANSOPRAZOLE

Application Number

202727

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2012-05-18

Regulatory Status

OTC

2017
28 Jun
OTC Application: 200810

Drug Name

OLOPATADINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 0.1% BASE

Approval Date

2017-06-28

200810 / 1

Active Ingredient

OLOPATADINE HYDROCHLORIDE

Application Number

200810

Product Number

1

Dosage Form

-

Strength

EQ 0.1% BASE

Approval Date

2017-06-28

Regulatory Status

OTC

2025
28 Feb
OTC Application: 219557

Drug Name

OLOPATADINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 0.2% BASE

Approval Date

2025-02-28

219557 / 1

Active Ingredient

OLOPATADINE HYDROCHLORIDE

Application Number

219557

Product Number

1

Dosage Form

-

Strength

EQ 0.2% BASE

Approval Date

2025-02-28

Regulatory Status

OTC

Related Databases
  • FDA Inspections
    25 View
  • EDQM CEP
    2 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    84 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
10 total
  • OTC
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ADAPALENE

Application Number

91314

Product Number

1

Active Ingredient

ADAPALENE

Dosage Form

-

Strength

0.1%

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit